Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The National Cancer Institute (NCI) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 8 clinical trials at NIH that match your search criteria

Cancer by PI: Giaccone, Giuseppe M.D., Ph.D.

Trial and Protocol Number Lung Cancer	Principal Investigator	Referral Contact
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Adults With Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Two or More Prior Treatment Regimens NCI-09-C-0018	Giuseppe Giaccone 301-496-4916	Corrine Keen 301-496-3778 ckeen@mail.nih.gov
Pilot Trial of Pioglitazone in Patients Undergoing Surgical Resection of Non-Small Cell Lung Cancer NCI-08-C-0208	Giuseppe Giaccone 301-496-4916	Arlene Berman 301-435-5609 arleneb@mail.nih.gov
A Phase II, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients With Advanced NSCLC After Failure of at Least One Prior Chemotherapy Regime and Failure of Prior Treatment With Erlotinib NCI-08-C-0086	Giuseppe Giaccone 301-496-4916	Arlene Berman 301-435-5609 arleneb@mail.nih.gov
Registration Phase III Study of Lucanix™ (Belagenpumatucel-L) in Advanced Non-Small Cell Lung Cancer: An International Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Lucanix™ Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Regimen of Front-Line, Platinum-Based Combination Chemotherapy NCI-08-C-0083	Giuseppe Giaccone 301-496-4916	Arlene Berman 301-435-5609 arleneb@mail.nih.gov
Phase II Study of BAY 43-9006 (Sorafenib) With Evaluation of Ras Signal Pathway in Patients With Relapsed Non-Small Cell Lung Cancer NCI-05-C-0049	Giuseppe Giaccone 301-496-4916	Arlene Berman 301-435-5609 arleneb@mail.nih.gov

Trial and Protocol Number Solid Tumor (Adult)	Principal Investigator	Referral Contact
A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors NCI-08-C-0128	Giuseppe Giaccone 301-496-4916	Janelle Bingham 301-435-2715 jbingham@mail.nih.gov
Phase I Study of SNX-5422 Mesylate in Adults With Refractory Solid Tumor Malignancies and Lymphomas NCI-08-C-0091	Giuseppe Giaccone 301-496-4916	Janelle Bingham 301-435-2715 jbingham@mail.nih.gov

Trial and Protocol Number Thymoma/Thymic Carcinoma	Principal Investigator	Referral Contact
Multicenter Phase II Study of Belinostat (PXD101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma NCI-08-C-0033	Giuseppe Giaccone 301-496-4916	Arlene Berman 301-435-5609 arleneb@mail.nih.gov

If there are no studies listed for your specific disease type, please search under:

Solid Tumor (advanced malignancy)